Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer. 2020 Jan 15;126(2):416-424. doi: 10.1002/cncr.32553. Epub 2019 Oct 4.
Many parents of children with advanced cancer pursue curative goals when cure is no longer possible. To the authors' knowledge, no pediatric studies to date have prospectively evaluated prognosis communication or influences on decision making in poor-prognosis childhood cancer.
The authors conducted a prospective cohort study at 9 pediatric cancer centers that enrolled 95 parents of children with recurrent or refractory, high-risk neuroblastoma (63% of those who were approached), a condition for which cure rarely is achieved. Parents were surveyed regarding the child's likelihood of cure; their primary goal of care; the child's symptoms, suffering, and quality of life; and regret concerning the last treatment decision. Medical records identified care and treatment decisions.
Only 26% of parents recognized that the chance of cure was <25%. When asked to choose a single most important goal of care, approximately 72% chose cure, 10% chose longer life, and 18% chose quality of life. Parents were more likely to prioritize quality of life when they recognized the child's poor prognosis (P = .002). Approximately 41% of parents expressed regret about the most recent treatment decision. Parents were more likely to experience regret if the child had received higher intensity medical care (odds ratio [OR], 3.14; 95% CI, 1.31-7.51), experienced suffering with limited benefit from the most recent treatment (OR, 4.78; 95% CI, 1.16-19.72), or experienced suffering from symptoms (OR, 2.91; 95% CI, 1.18-7.16).
Parents of children with poor-prognosis cancer frequently make decisions based on unrealistic expectations. New strategies for effective prognosis communication are needed.
许多患有晚期癌症的儿童的父母在无法治愈时仍追求治愈目标。据作者所知,迄今为止,尚无儿科研究前瞻性评估预后沟通或对预后不良的儿童癌症决策的影响。
作者在 9 个儿科癌症中心进行了一项前瞻性队列研究,纳入了 95 名患有复发性或难治性高危神经母细胞瘤的儿童的父母(其中 63%的人被接触到),这种疾病很少能治愈。父母接受了关于孩子治愈可能性的调查;他们护理的主要目标;孩子的症状、痛苦和生活质量;以及对最后治疗决策的遗憾。医疗记录确定了护理和治疗决策。
只有 26%的父母认为治愈的机会<25%。当被要求选择一个单一的最重要的护理目标时,大约 72%的父母选择治愈,10%的父母选择延长生命,18%的父母选择生活质量。当父母认识到孩子的预后较差时,他们更有可能将生活质量放在首位(P=0.002)。大约 41%的父母对最近的治疗决定表示遗憾。如果孩子接受了更高强度的医疗护理(优势比[OR],3.14;95%置信区间[CI],1.31-7.51)、最近的治疗带来的痛苦有限但受益(OR,4.78;95% CI,1.16-19.72)或因症状而痛苦(OR,2.91;95% CI,1.18-7.16),则父母更有可能感到遗憾。
患有预后不良癌症的儿童的父母经常根据不切实际的期望做出决策。需要新的有效预后沟通策略。